TMCI vs. GUTS, TCMD, SKIN, LUNG, TLSI, SGHT, INO, NVRO, ANGO, and UTMD
Should you be buying Treace Medical Concepts stock or one of its competitors? The main competitors of Treace Medical Concepts include Fractyl Health (GUTS), Tactile Systems Technology (TCMD), Beauty Health (SKIN), Pulmonx (LUNG), TriSalus Life Sciences (TLSI), Sight Sciences (SGHT), Inovio Pharmaceuticals (INO), Nevro (NVRO), AngioDynamics (ANGO), and Utah Medical Products (UTMD). These companies are all part of the "surgical & medical instruments" industry.
Treace Medical Concepts (NASDAQ:TMCI) and Fractyl Health (NASDAQ:GUTS) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, community ranking, risk, institutional ownership, profitability, earnings, media sentiment, dividends and valuation.
In the previous week, Treace Medical Concepts had 14 more articles in the media than Fractyl Health. MarketBeat recorded 27 mentions for Treace Medical Concepts and 13 mentions for Fractyl Health. Treace Medical Concepts' average media sentiment score of 0.63 beat Fractyl Health's score of 0.14 indicating that Treace Medical Concepts is being referred to more favorably in the media.
Fractyl Health has a net margin of 0.00% compared to Treace Medical Concepts' net margin of -27.93%. Fractyl Health's return on equity of 0.00% beat Treace Medical Concepts' return on equity.
Treace Medical Concepts presently has a consensus target price of $12.21, suggesting a potential upside of 116.18%. Fractyl Health has a consensus target price of $22.00, suggesting a potential upside of 228.85%. Given Fractyl Health's stronger consensus rating and higher probable upside, analysts plainly believe Fractyl Health is more favorable than Treace Medical Concepts.
84.1% of Treace Medical Concepts shares are owned by institutional investors. 24.4% of Treace Medical Concepts shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Treace Medical Concepts has higher revenue and earnings than Fractyl Health.
Treace Medical Concepts received 21 more outperform votes than Fractyl Health when rated by MarketBeat users. However, 100.00% of users gave Fractyl Health an outperform vote while only 53.33% of users gave Treace Medical Concepts an outperform vote.
Summary
Fractyl Health beats Treace Medical Concepts on 8 of the 15 factors compared between the two stocks.
Get Treace Medical Concepts News Delivered to You Automatically
Sign up to receive the latest news and ratings for TMCI and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding TMCI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Treace Medical Concepts Competitors List
Related Companies and Tools
